A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects (opens ClinicalTrials.gov)
- Sponsor
- The Affiliated Hospital of Qingdao University
- Enrolment
- 32
- Started
- 2021-07-16
- Last update
- 2022-02-07
Conditions: Therapeutic Equivalency
Interventions: Liraglutide injection, Liraglutide injection(Victoza®)